IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Aug 1, 2025, 4:00 PM
1.310
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:00 PM EDT

Company Description

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases.

The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010.

IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.

IGM Biosciences, Inc.
IGM Biosciences logo
CountryUnited States
Founded1993
IPO DateSep 18, 2019
IndustryBiotechnology
SectorHealthcare
Employees149
CEOMary Harler

Contact Details

Address:
325 East Middlefield Road
Mountain View, California 94043
United States
Phone650 965 7873
Websiteigmbio.com

Stock Details

Ticker SymbolIGMS
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$16.00
CIK Code0001496323
CUSIP Number449585108
ISIN NumberUS4495851085
Employer ID77-0349194
SIC Code2834

Key Executives

NamePosition
Mary Beth Harler M.D.Chief Executive Officer and Director
Misbah Tahir CPAChief Financial Officer
Dr. Lisa L. Decker Ph.D.Chief Business Officer
Paul C. Graffagnino J.D.Senior Vice President of Legal Affairs
Suzette TauberChief Human Resources Officer

Latest SEC Filings

DateTypeTitle
Jul 31, 202510-QQuarterly Report
Jul 16, 2025SC 14D9Filing
Jul 16, 2025SC TO-TFiling
Jul 9, 2025SCHEDULE 13GFiling
Jul 1, 2025SC14D9CFiling
Jul 1, 20258-KCurrent Report
Jun 11, 20258-KCurrent Report
May 29, 20258-KCurrent Report
May 13, 202510-QQuarterly Report
May 8, 20258-KCurrent Report